J&J is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a big test for an IPO market that has been in the doldrums for the past year.
Wall Street Journal
J&J is poised to begin a roadshow to pitch shares of its consumer-healthcare business, in a big test for an IPO market that has been in the doldrums for the past year.